Hively Brad
Insider CIK 1891124 · STLN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STLN Starling Oncology, Inc. | S Sale | 2026-08-21 | 2026-08-24 | 298,853 | $6.51 | $1.95M | 411,976 | SEC↗ |
| STLN Starling Oncology, Inc. | S Sale | 2026-08-21 | 2026-08-24 | 298,853 | $6.51 | $1.95M | 411,976 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2026-07-27 | 2026-07-29 | 27,108 | — | $0 | 710,829 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2026-07-27 | 2026-07-29 | 27,108 | — | $0 | 710,829 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2025-12-15 | 2025-12-16 | 13,333 | $3.77 | $50.3K | 683,721 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2025-11-20 | 2025-11-24 | 41,667 | — | $0 | 664,647 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2025-11-20 | 2025-11-24 | 32,407 | — | $0 | 697,054 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2025-08-19 | 2025-08-21 | 20,221 | $4.06 | $82.1K | 622,980 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-05 | 684,528 | — | $0 | 0 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-05 | 105,320 | — | $0 | 0 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-05 | 131,297 | — | $0 | 0 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-05 | 946,460 | — | $0 | 0 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise | 2025-06-03 | 2025-06-05 | 684,528 | $0.85 | $581.8K | 1,396,561 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise | 2025-06-03 | 2025-06-05 | 105,320 | $0.48 | $50.6K | 1,501,881 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise | 2025-06-03 | 2025-06-05 | 131,297 | $1.87 | $245.5K | 1,633,178 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise | 2025-06-03 | 2025-06-05 | 946,460 | $0.85 | $804.5K | 2,579,638 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 1,867,605 | $2.87 | $5.36M | 712,033 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 108,532 | $2.87 | $311.5K | 603,501 | SEC↗ |
| TOI Oncology Institute, Inc. | P Buy deriv | 2025-03-26 | 2025-04-28 | 22,640 | $0.13 | $2.9K | 22,640 | SEC↗ |
| TOI Oncology Institute, Inc. | P Buy | 2025-03-26 | 2025-04-28 | 45,280 | $1.04 | $47.1K | 712,033 | SEC↗ |
| TOI Oncology Institute, Inc. | P Buy deriv | 2025-03-26 | 2025-03-28 | 4,528 | $0.13 | $589 | 4,528 | SEC↗ |
| TOI Oncology Institute, Inc. | P Buy | 2025-03-26 | 2025-03-28 | 9,056 | $1.04 | $9.4K | 675,809 | SEC↗ |
| TOI Oncology Institute, Inc. | P Buy | 2024-12-02 | 2024-12-02 | 50,000 | $0.15 | $7.5K | 666,753 | SEC↗ |
| TOI Oncology Institute, Inc. | P Buy | 2024-11-26 | 2024-12-02 | 250,000 | $0.17 | $42.5K | 616,753 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2024-11-22 | 2024-11-25 | 44,000 | — | $0 | 720,203 | SEC↗ |
| TOI Oncology Institute, Inc. | J Other | 2024-11-12 | 2024-12-02 | 353,450 | — | $0 | 366,753 | SEC↗ |
| TOI Oncology Institute, Inc. | D To issuer | 2024-06-17 | 2024-06-20 | 18,121 | $0.46 | $8.3K | 676,203 | SEC↗ |
| TOI Oncology Institute, Inc. | D To issuer | 2024-05-22 | 2024-05-23 | 19,526 | $0.58 | $11.3K | 694,324 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2023-12-26 | 2023-12-28 | 42,652 | — | $0 | 713,850 | SEC↗ |
| TOI Oncology Institute, Inc. | D To issuer | 2023-11-21 | 2023-11-22 | 25,867 | $2.19 | $56.6K | 671,198 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise deriv | 2023-11-17 | 2023-11-21 | 25,000 | — | $0 | 1,745,431 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise | 2023-11-17 | 2023-11-21 | 25,000 | $0.85 | $21.3K | 722,065 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2023-11-17 | 2023-11-21 | 25,000 | $2.24 | $56.0K | 697,065 | SEC↗ |
| TOI Oncology Institute, Inc. | D To issuer | 2023-11-14 | 2023-11-15 | 27,117 | $2.39 | $64.8K | 697,065 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise deriv | 2023-11-13 | 2023-11-15 | 47,000 | — | $0 | 1,770,431 | SEC↗ |
| TOI Oncology Institute, Inc. | M Exercise | 2023-11-13 | 2023-11-15 | 47,000 | $0.85 | $40.0K | 771,182 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2023-11-13 | 2023-11-15 | 47,000 | $2.52 | $118.4K | 724,182 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award deriv | 2023-03-17 | 2023-03-21 | 421,280 | — | $0 | 421,280 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2023-03-17 | 2023-03-21 | 168,512 | — | $0 | 724,182 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award deriv | 2022-11-17 | 2022-11-21 | 525,188 | — | $0 | 525,188 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2022-11-17 | 2022-11-21 | 103,469 | — | $0 | 555,670 | SEC↗ |
| TOI Oncology Institute, Inc. | D To issuer | 2022-11-15 | 2022-11-17 | 9,718 | $2.03 | $19.7K | 452,201 | SEC↗ |
| TOI Oncology Institute, Inc. | S Sale | 2022-11-15 | 2022-11-22 | 9,718 | $2.03 | $19.7K | 452,201 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 88,090 | — | $0 | 88,090 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award deriv | 2022-03-21 | 2022-03-29 | 550,563 | — | $0 | 550,563 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2022-03-21 | 2022-03-23 | 108,469 | — | $0 | 461,919 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award deriv | 2021-11-12 | 2021-11-16 | 823,971 | — | $0 | 0 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award deriv | 2021-11-12 | 2021-11-16 | 993,460 | — | $0 | 0 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2021-11-12 | 2021-11-18 | 212,070 | — | $0 | 363,450 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2021-11-12 | 2021-11-18 | 141,380 | — | $0 | 141,380 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2021-01-12 | 2021-11-16 | 141,380 | — | $0 | 141,380 | SEC↗ |
| TOI Oncology Institute, Inc. | A Award | 2021-01-12 | 2021-11-16 | 212,070 | — | $0 | 212,070 | SEC↗ |